Please provide your contact information in order to receive updates on future developments in the diagnosis and treatment of pseudobulbar affect (PBA) from Avanir Pharmaceuticals, the sponsor of this Web site. We take your privacy very seriously. Your information will be subject to our privacy policy on this Web site.